Parasin I
| Internal ID | 9c243a9a-face-474d-8a5f-e01b7a4190a9 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-5-carbamimidamido-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]pentanoyl]amino]acetyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoic acid |
| SMILES (Canonical) | CC(C)C(C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCCN)NC(=O)CNC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CCCCN)N |
| SMILES (Isomeric) | C[C@H]([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)N)O |
| InChI | InChI=1S/C82H154N34O24/c1-43(2)63(115-74(134)50(21-8-13-31-85)107-60(122)38-99-59(121)37-101-69(129)55(27-28-58(89)120)110-72(132)49(20-7-12-30-84)106-62(124)40-102-68(128)48(24-16-34-96-80(90)91)105-61(123)39-100-67(127)47(88)19-6-11-29-83)77(137)111-53(25-17-35-97-81(92)93)71(131)104-44(3)65(125)108-51(22-9-14-32-86)70(130)103-45(4)66(126)109-52(23-10-15-33-87)75(135)116-64(46(5)119)78(138)112-54(26-18-36-98-82(94)95)73(133)113-56(41-117)76(136)114-57(42-118)79(139)140/h43-57,63-64,117-119H,6-42,83-88H2,1-5H3,(H2,89,120)(H,99,121)(H,100,127)(H,101,129)(H,102,128)(H,103,130)(H,104,131)(H,105,123)(H,106,124)(H,107,122)(H,108,125)(H,109,126)(H,110,132)(H,111,137)(H,112,138)(H,113,133)(H,114,136)(H,115,134)(H,116,135)(H,139,140)(H4,90,91,96)(H4,92,93,97)(H4,94,95,98)/t44-,45-,46+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-,64-/m0/s1 |
| InChI Key | NFEQUGKCQWAGLY-UAAVROCESA-N |
| Popularity | 10 references in papers |
| Molecular Formula | C82H154N34O24 |
| Molecular Weight | 2000.30 g/mol |
| Exact Mass | 1999.1875219 g/mol |
| Topological Polar Surface Area (TPSA) | 1010.00 Ų |
| XlogP | -15.70 |
| Atomic LogP (AlogP) | -15.59 |
| H-Bond Acceptor | 32 |
| H-Bond Donor | 38 |
| Rotatable Bonds | 76 |
| 219552-69-9 |
| KGRGKQGGKVRAKAKTRSS |
| CHEMBL1240726 |
| RS-2018 |
| Parasin I (KGRGKQGGKVRAKAKTRSS-acid) |
| J-014371 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5456 | 54.56% |
| Caco-2 | - | 0.8576 | 85.76% |
| Blood Brain Barrier | - | 0.5500 | 55.00% |
| Human oral bioavailability | - | 0.7000 | 70.00% |
| Subcellular localzation | Mitochondria | 0.7726 | 77.26% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8678 | 86.78% |
| OATP1B3 inhibitior | + | 0.9365 | 93.65% |
| MATE1 inhibitior | - | 0.8800 | 88.00% |
| OCT2 inhibitior | - | 0.7250 | 72.50% |
| BSEP inhibitior | + | 0.9479 | 94.79% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.7835 | 78.35% |
| CYP3A4 substrate | + | 0.6612 | 66.12% |
| CYP2C9 substrate | - | 0.5984 | 59.84% |
| CYP2D6 substrate | - | 0.8243 | 82.43% |
| CYP3A4 inhibition | - | 0.8751 | 87.51% |
| CYP2C9 inhibition | - | 0.8808 | 88.08% |
| CYP2C19 inhibition | - | 0.8483 | 84.83% |
| CYP2D6 inhibition | - | 0.9004 | 90.04% |
| CYP1A2 inhibition | - | 0.8628 | 86.28% |
| CYP2C8 inhibition | + | 0.4593 | 45.93% |
| CYP inhibitory promiscuity | - | 0.9824 | 98.24% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6173 | 61.73% |
| Eye corrosion | - | 0.9828 | 98.28% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7969 | 79.69% |
| Skin corrosion | - | 0.9385 | 93.85% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6905 | 69.05% |
| Micronuclear | + | 0.5600 | 56.00% |
| Hepatotoxicity | - | 0.6291 | 62.91% |
| skin sensitisation | - | 0.8642 | 86.42% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.5059 | 50.59% |
| Mitochondrial toxicity | - | 0.5000 | 50.00% |
| Nephrotoxicity | - | 0.6977 | 69.77% |
| Acute Oral Toxicity (c) | III | 0.6374 | 63.74% |
| Estrogen receptor binding | + | 0.5411 | 54.11% |
| Androgen receptor binding | + | 0.7447 | 74.47% |
| Thyroid receptor binding | + | 0.7060 | 70.60% |
| Glucocorticoid receptor binding | + | 0.7753 | 77.53% |
| Aromatase binding | + | 0.7859 | 78.59% |
| PPAR gamma | + | 0.7720 | 77.20% |
| Honey bee toxicity | - | 0.7982 | 79.82% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.7500 | 75.00% |
| Fish aquatic toxicity | - | 0.8481 | 84.81% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.73% | 83.82% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 99.56% | 98.94% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.48% | 98.95% |
| CHEMBL236 | P41143 | Delta opioid receptor | 99.21% | 99.35% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.42% | 97.23% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.86% | 100.00% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 97.86% | 85.00% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 97.73% | 98.33% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.53% | 96.67% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 97.37% | 94.45% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 97.32% | 100.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.87% | 98.33% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 96.81% | 95.17% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.21% | 99.17% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.00% | 96.09% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 95.96% | 97.21% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.91% | 91.11% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 95.86% | 98.89% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 95.40% | 96.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.35% | 96.47% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 94.97% | 98.05% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 94.79% | 96.28% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.20% | 96.03% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 93.89% | 99.77% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 93.55% | 90.20% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.24% | 93.56% |
| CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 93.13% | 97.88% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 92.85% | 90.17% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 92.84% | 93.10% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 92.78% | 92.32% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 92.60% | 95.20% |
| CHEMBL2973 | O75116 | Rho-associated protein kinase 2 | 92.51% | 96.73% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 92.40% | 93.18% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 92.32% | 95.71% |
| CHEMBL3776 | Q14790 | Caspase-8 | 92.22% | 97.06% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 91.49% | 99.17% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.43% | 95.00% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 91.07% | 92.29% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.72% | 93.00% |
| CHEMBL4296013 | Q5VWK5 | Interleukin-23 receptor | 89.82% | 88.00% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 89.62% | 91.38% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 89.24% | 97.29% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 89.00% | 89.63% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.48% | 89.50% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 87.65% | 96.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 87.45% | 100.00% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 87.19% | 86.67% |
| CHEMBL1628481 | P35414 | Apelin receptor | 86.74% | 97.89% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 86.74% | 90.71% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.61% | 96.90% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.40% | 88.42% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 85.72% | 91.19% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 85.14% | 82.38% |
| CHEMBL1795117 | Q8TEK3 | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 84.43% | 93.56% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 84.30% | 89.33% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.76% | 95.83% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 83.52% | 95.50% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.43% | 94.33% |
| CHEMBL3308 | P55212 | Caspase-6 | 83.29% | 97.56% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 82.43% | 94.45% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 82.28% | 94.00% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.24% | 96.67% |
| CHEMBL1991 | O14920 | Inhibitor of nuclear factor kappa B kinase beta subunit | 81.90% | 97.15% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 81.72% | 82.86% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 81.20% | 97.09% |
| CHEMBL4444 | P04070 | Vitamin K-dependent protein C | 81.20% | 93.89% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.84% | 98.75% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.65% | 94.66% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 80.14% | 94.01% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 80.07% | 80.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 16198073 |
| LOTUS | LTS0016459 |
| wikiData | Q105178415 |